Contaminants of PC-SPES are not responsible for cytotoxicity in human small-cell lung carcinoma cells

Cancer Letters

Volumn 220, Issue 2, 2005, Pages 171-175

  Sadava, David ^a   Winesburg, Jennifer ^a  

^a KECK GRADUATE INSTITUTE   (United States)

Author keywords

Contamination; Herbal extracts; Human lung cancer; PC SPES

Indexed keywords

DIETHYLSTILBESTROL; DNA FRAGMENT; INDOMETACIN; PC SPES; PLANT EXTRACT; WARFARIN;

APOPTOSIS; ARTICLE; BATCH PROCESS; CALCULATION; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONTAMINATION; DRUG DETERMINATION; DRUG EFFECT; HUMAN; HUMAN CELL; IC 50; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 17644409742     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.09.010     Document Type: Article

References (15)

1. G.P. Kalemkerian, and F.P. Worden Therapeutic advances in SCLC Expert Opin. Invest. Drugs 9 2000 65 79
2. D.H. Johnson Progression in the management of small-cell lung carcinoma J. Clin. Oncol. 20 2002 4118 4120
3. K. Kelly New chemotherapy agents for small-cell lung carcinoma Chest 117 90041 2000 156 162
4. K. Nishio, T. Nakamura, Y. Koh, T. Suzuki, H. Fukumoto, and N. Saijo Drug resistance in lung cancer Curr. Opin. Oncol. 11 1999 109 115
5. J. Mattern, and M. Volm Resistance mechanisms in human lung cancer Invasion Metastasis 15 1995 81 94
6. R.S. DiPaola, H. Zhang, G. Lambert, R. Meeker, E. Licitra, and M. Rafi Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer N. Engl. J. Med. 339 1998 785 791
7. E. Small, M. Frolcih, R. Bok, K. Shinohara, G. Grossfeld, and Z. Rozenblatt Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer J. Clin. Oncol. 18 2000 3395 3403
8. L.S. Marks, R. DiPaola, P. Nelson, S. Chen, D. Heber, and A. Belldegrun PC-SPES: herbal formulation for prostate cancer Urology 60 2002 369 377
9. T. Ikezoe, S. Chen, Y. Tang, D. Heber, H. Taguchi, and H.P. Koeffler PC-SPES: molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells Int. J. Oncol. 23 2003 1461 1470
10. M. Sovak, A. Seligson, M. Konas, M. Hajduch, M. Dolezal, M. Machala, and R. Nagourney Herbal composition PC-SPES for management of prostate cancer: identification of active principles J. Natl Cancer Inst. 94 2002 1275 1281
11. E.S. Guns, S. Goldenberg, and P. Brown Mass spectral analysis of PC-SPES confirms the presence of diethylstilbesterol Can. J. Urol. 9 2002 1684 1688
12. T. Wadsworth, T. Poonyagariyagom, E. Sullivan, D. Koop, and C. Roselli In vivo effect of PC-SPES on prostate growth and hepatic CYP3A expression in rats J. Pharmacol. Exp. Ther. 306 2003 187 194
13. P.S. Nelson, and B. Montgomery Unconventional therapy for prostate cancer: good, bad or questionable? Nat. Rev. Cancer 3 2003 8445 8858
14. D. Sadava, J. Ahn, M. Zhan, M.-L. Pang, J. Ding, and S.E. Kane Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant human small-cell lung carcinoma cells Cancer Chemother. Pharmacol. 49 2002 261 266
15. K. Minato, F. Kanzawa, K. Nishio, K. Nakagawa, Y. Fujiwara, and N. Saijo Characterization of an etoposide-resistant human small-cell lung cancer cell line Cancer Chemother. Pharmacol. 26 1990 313 317